Posted: March 9th, 2016
Astrazeneca and Shionogi v Resolution, Court of Appeal the Hague, the Netherlands, 16 February 2016, Case no. 200.174.337/01, with thanks to Willem Hoyng, Jeroen den Hartog en Judith Krens, HOYNG ROKH MONEGIER, for sending in the judgment and translation in English Scope of protection. The patent (SPC) in suit relates to a new active substanse […]
READ MOREPosted: March 3rd, 2016
(1) Actavis UK Limited (2) Actavis Group EHF (3) Actavis Group PTC EHF (4) Medis EHF (5) Actavis Deutschland GMBH & CO. KG (6) Medis Pharma GMBH (7) Medis Pharma France SAS (8) Actavis France SAS (9) Actavis Spain S.A. (10) Actavis Italy SPA A Socio Unico v Eli Lilly & Company, High Court of […]
READ MOREPosted: February 25th, 2016
Celltrion Inc v (1) Biogen Idec Inc. (2) F. Hoffmann-La-Roche AG & (3) Genentech Inc., High Court of Justice of England and Wales, Patents Court (Carr J.), London UK, 22 January 2016, Neutral Citation Number: [2016] EWHC 188 (Pat) On 22 January 2016, Carr J granted the Claimant’s application for an order that its claim […]
READ MOREPosted: February 17th, 2016
Global Flood Defence Systems Limited and UK Flood Barriers Limited v Johan Van Den Noort Beheer BV, Johann Heinrich Reindert Van Den Noort and Flood Control International Limited, High Court of Justice of England and Wales, Intellectual Property Enterprise Court (HHJ Hacon), London UK, 5 February 2016, Neutral Citation Number: [2016] EWHC 189 (IPEC) On […]
READ MOREPosted: February 16th, 2016
Regeneron Pharmaceuticals Inc v Kymab Limited and Novo Nordisk A/S, High Court of England and Wales (Carr J), London, UK, 1 February 2016, Neutral Citation Number: [2016] EWHC 87 (Pat). On 3 February 2016 the Patents Court (Carr J) held that the disputed claims of two of Regeneron’s patents relating to transgenic mice used for […]
READ MOREPosted: February 15th, 2016
Gamesa v Aloys Wobben, 15th Section of the Provincial Court of Appeals of Barcelona, Spain, 7 January 2016, Docket No. 443/2014-2ª On 14 January 2016, Section 15th of the Provincial Court of Appeals of Barcelona served its decision of 7 January in the GAMESA v. WOBBEN case. This is a very interesting Judgement not only […]
READ MOREPosted: February 15th, 2016
On 21st December 2015, The Supreme Court handed down a decision in the case of AstraZeneca AB & others v Laboratorios Alter and & others (EDJ 2015/244058). AstraZeneca had filed an action against several generic companies for infringement of an SPC for the product quetaipina: The SPC’s basic patent was EP 228. EP 228 was […]
READ MOREPosted: February 10th, 2016
On 1 February 2016 the Intellectual Property Enterprise Court handed down a decision of Judge Hacon in the case of Global Flood Defence Systems Ltd & others v Johann Van Den Noort Beheer BV & others [2016] EWHC 99 (IPEC) on the subject of groundless threats and fraudulent misrepresentation. The alleged groundless threats were made […]
READ MOREPosted: February 10th, 2016
AP Racing Limited v Alcon Components Limited, High Court of Justice of England and Wales, Intellectual Property Enterprise Court (HHJ Hacon), London UK, 28 January 2016, Neutral Citation Number: [2016] EWHC 116 (IPEC) In an inquiry as to damages, the Intellectual Property Enterprise Court (the “IPEC”) has awarded AP Racing Limited (“AP Racing”) almost £0.5 […]
READ MOREPosted: January 26th, 2016
Warner-Lambert Company LLC v. the State of The Netherlands (Dutch Medicines Evaluation Board), District Court of The Hague, The Netherlands, 15 January 2016, Case file number: C/09/498943 / KG ZA 15-1656 Warner-Lambert Company LLC is part of the Pfizer group of companies (hereinafter: “WLC”). Pfizer brings a medicine on the market (including The Netherlands) under […]
READ MORE